Skip directly to search Skip directly to A to Z list Skip directly to site content
CDC Home

Volume 16, Number 3—March 2010


Preparing a Community Hospital to Manage Work-related Exposures to Infectious Agents in BioSafety Level 3 and 4 Laboratories

George F. RisiComments to Author , Marshall E. Bloom, Nancy P. Hoe, Thomas Arminio, Paul Carlson, Tamara Powers, Heinz Feldmann, and Deborah Wilson
Author affiliations: Infectious Disease Specialists, PC, Missoula, Montana, USA (G.F. Risi); St. Patrick Hospital and Health Sciences Center, Missoula (T. Powers); National Institutes of Health, Bethesda, Maryland, USA (G.F. Risi, N.P. Hoe, T. Arminio, P. Carlson, D. Wilson); Rocky Mountain Laboratories, Hamilton, Montana, USA (M.E. Bloom, H. Feldmann)

Main Article

Table 2

Infections caused by laboratory exposure to hemorrhagic fever viruses*

Virus Incident
Ebola Fingerstick while manipulating infected guinea pig tissue, 1977 (5); percutaneous exposure to blood from a Zaire Ebola virus–infected rodent, 2004 (7)
Marburg 3 laboratory acquired infections since the mid-1980s; 1 death occurred in Russia; no details available (8)
Crimean–Congo hemorrhagic fever 8 cases before 1980 compiled by SALS; no details available (9)
Lassa 1 case reported in 1970 with limited details provided (10)
Junin 21 cases before 1980 compiled by SALS; no details available (9)
Machupo 1 person exposed to aerosolized blood from a broken test tube (11)

*SALS, Subcommittee on Arbovirus Laboratory Safety.

Main Article

Top of Page The U.S. Government's Official Web PortalDepartment of Health and Human Services
Centers for Disease Control and Prevention   1600 Clifton Rd. Atlanta, GA 30333, USA
800-CDC-INFO (800-232-4636) TTY: (888) 232-6348 - Contact CDC–INFO